Table 6 Patient-reported and anthropometric data in participants who completed all follow-up (n = 22)

KOOS-Pain

61.8 ± 12.0^b

63.1 ± 11.4

68.8 ± 12.2^c

68.4 ± 12.3

6.6 ± 12.6

[0.9 to 12.4]

8–10

KOOS-Symptoms

56.9 ± 14.3^b

57.3 ± 15.4

58.6 ± 16.7^c

62.5 ± 17.7

5.6 ± 15.1

[−1.3 to 12.5]

8–10

KOOS-ADL

68.2 ± 15.9^b

72.2 ± 13.2^b

75.8 ± 14.6^c

78.3 ± 14.4

10.1 ± 14.3

[3.6 to 16.6]

8–10

KOOS-Sport/Rec

35.7 ± 27.3^b

47.4 ± 27.9^b

46.8 ± 25.2^c

46.9 ± 29.6

11.2 ± 19.7

[2.2 to 20.2]

8–10

KOOS-QoL

42.0 ± 16.4^b

46.3 ± 14.6^b

50.9 ± 14.5^c

50.8 ± 13.7

8.8 ± 14.7

[2.1 to 15.5]

8–10

KOOS₄

57.2 ± 10.9^b

59.95 ± 10.7^b

63.5 ± 10.8^c

65.0 ± 12.4

7.8 ± 11.5

[2.5 to 13.0]

8–10

EQ 5 D Utility

0.70 ± 0.16^b

0.74 ± 0.1

0.74 ± 0.11^c

0.75 ± 0.12

0.04 ± 0.16

[−0.03 to 0.11]

N/A

EQ 5 D VAS

75.2 ± 15.1^b

77.5 ± 15.1

78.9 ± 15.4^c

81.6 ± 14.6

6.3 ± 16.0

[−0.9 to 13.6]

N/A

Average Pain (0-100 mm)

52.6 ± 22.7^b

52.1 ± 21.3^b

41.6 ± 23.0^d

43.6 ± 27.5^c

−8.9 ± 35.6

[−26.1 to 8.2]

N/A

BMI, kg/cm²

30.7 ± 4.8^d

29.7 ± 4.6^b

29.5 ± 4.6^c

29.6 ± 4.3^b

−1.0 ± 0.8

[−1.4 to −0.7]

N/A

Weight, kg

86.6 ± 15.0^d

83.7 ± 13.9^b

82.7 ± 13.8^c

83.6 ± 13.7^b

−3.0 ± 2.3

[−4.1 to −1.8]

N/A